Blood biomarker predicts dementia risk in Mexican Americans

March 24, 2022

Blood levels of a biomarker called glial fibrillary acidic protein (GFAP) may uniquely aid prediction of dementia in Mexican Americans, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and collaborating institutions reported March 24.

Experimental gene therapy allows kids with inherited deafness to hear
Gene therapy has allowed several children born with inherited deafness to hear.
Health care workforce turnover increased after pandemic
There was an increase in health care workforce turnover after the pandemic, according to a study published online Jan. 26 in JAMA Health Forum.
Immunotherapy post-surgery found to improve overall survival for kidney cancer
For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.
Study finds people with OCD are more likely to die earlier, of any cause
People with obsessive-compulsive disorder, or OCD for short, are 82% more likely to die earlier—from natural or unnatural causes—than people without the condition, a new study reveals.
New tool helps predict progression of Alzheimer's
About 55 million people worldwide are living with dementia, according to the World Health Organization. The most common form is Alzheimer's disease, an incurable condition that causes brain function to deteriorate.

Blood biomarker predicts dementia risk in Mexican Americans

Recent Posts

JUST IN